FeesSafety
Pluang+

Cars.com names Mausam Bhatt as Chief Product Officer to boost AI-driven marketplace growth.

Market News
29 Oct 2026, 14:30 WIB
PRNewsWire
View Source
Bullish
Cars.com names Mausam Bhatt as Chief Product Officer to boost AI-driven marketplace growth.

Cars.com has appointed Mausam Bhatt as its new Chief Product Officer, effective November 2, 2026. Bhatt brings extensive experience from leading roles at Rithum, Realtor.com, Google Shopping, and Flipkart, focusing on building connected marketplaces and AI-driven products. He will lead product strategy to enhance Cars.com's consumer marketplace by integrating AI, data, and dealer solutions for better user experiences and growth. This move aims to accelerate Cars.com's evolution into a more intelligent and connected automotive sales platform.

Cars.com appoints Mausam Bhatt as Chief Product Officer to drive innovation in its marketplace. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Oct 29, 2026 17:42 WIB: out of 134 priced US stocks, 84 rose and 40 fell. Notable movers include VFC at USD 17.60 (+2.15%, typical hold time 64 days), BABA at USD 98.91 (-2.03%, typical hold time 113 days, Pluang order activity 44% Sell / 56% Buy), and BKNG at USD 150.84 (+1.96%, typical hold time 119 days, Pluang order activity 96% Sell / 4% Buy).

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App